Vyne Therapeutics logo

Vyne Therapeutics share price today

(VYNE)

Vyne Therapeutics share price is $4 & ₹343.24 as on 7 Jan 2025, 2.30 'hrs' IST

$4

0.54

(15.61%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Vyne Therapeutics share price in Dollar and Rupees. Guide to invest in Vyne Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vyne Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Vyne Therapeutics share price movements

  • Today's Low: $3.56
    Today's High: $4.00

    Day's Volatility :11.12%

  • 52 Weeks Low: $1.57
    52 Weeks High: $4.00

    52 Weeks Volatility :60.75%

Vyne Therapeutics Returns

PeriodVyne Therapeutics IncIndex (Russel 2000)
3 Months
90.11%
0.0%
6 Months
76.53%
0.0%
1 Year
51.75%
0.0%
3 Years
-80.97%
-19.8%

Vyne Therapeutics Key Statistics

in dollars & INR

Previous Close
$3.46
Open
$3.5
Today's High
$4.0
Today's Low
$3.555
Market Capitalization
$44.3M
Today's Volume
$92.1K
52 Week High
$4.0
52 Week Low
$1.57
Revenue TTM
$486.0K
EBITDA
$-29.2M
Earnings Per Share (EPS)
$1.72
PE Ratio
1.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-60.47%

How to invest in Vyne Therapeutics from India?

It is very easy for Indian residents to invest directly in Vyne Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vyne Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vyne Therapeutics or VYNE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vyne Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vyne Therapeutics shares which would translate to 0.215 fractional shares of Vyne Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vyne Therapeutics, in just a few clicks!

Returns in Vyne Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vyne Therapeutics investment value today

Current value as on today

₹1,78,661

Returns

₹78,661

(+78.66%)

Returns from Vyne Therapeutics Stock

₹75,439 (+75.44%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Vyne Therapeutics

150%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Vyne Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 150% more investors are searching Vyne Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Vyne Therapeutics

  • Eventide Asset Management, LLC

    9.45%

  • Cormorant Asset Management, LLC

    9.45%

  • Citadel Advisors Llc

    8.05%

  • Exome Asset Management LLC

    4.79%

  • Dsc Advisors LP

    4.72%

  • Palo Alto Investors, LLC

    3.02%

Analyst Recommendation on Vyne Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Vyne Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Vyne Therapeutics

What analysts predicted

Upside of 39.5%

Current:

$4.00

Target:

$5.58

Insights on Vyne Therapeutics

  • Price Movement

    In the last 1 month, VYNE stock has moved up by 29.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 198.0K → 121.0K (in $), with an average decrease of 38.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -6.18M → -12.15M (in $), with an average decrease of 26.9% per quarter
  • VYNE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 136.4%

Vyne Therapeutics Technicals Summary

Sell

Neutral

Buy

Vyne Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Vyne Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vyne Therapeutics Inc
25.82%
76.53%
51.75%
-80.97%
-96.73%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vyne Therapeutics Inc
1.74
1.74
NA
-0.6
-0.6
-0.35
NA
6.29
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vyne Therapeutics Inc
Buy
$44.3M
-96.73%
1.74
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Vyne Therapeutics

vyne therapeutics inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. it offers amzeeq, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older. the company is also developing fmx103, which is in phase iii clinical trials for the treatment of moderate-to-severe papulopustular rosacea in adults; and fcd105, a topical combination foam that is in phase ii clinical trials for the treatment of moderate-to-severe acne vulgaris. in addition, it is developing serlopitant, a once-daily oral nk1 receptor antagonist, used as a treatment option for pruritus associated with prurigo nodularis. the company was formerly known as menlo therapeutics inc. and changed its name to vyne therapeutics inc. in september 2020. vyne therapeutics inc. was founded in 2003 and is headquartered in bridgewater, new jersey.
Organization
Vyne Therapeutics
Employees
10
CEO
Mr. David T. Domzalski
Industry
Health Technology

Management People of Vyne Therapeutics

NameTitle
Mr. David T. Domzalski
CEO, President & Director
Dr. Iain A. Stuart Ph.D.
Chief Scientific Officer
Ms. Mutya Harsch J.D.
General Counsel, Chief Legal Officer & Company Secretary
Mr. Tyler Zeronda CPA
CFO & Treasurer
Dr. Subhashis Banerjee M.D.
Senior Vice President of Clinical Development
Dr. Darrell S. Rigel FAAD, M.D.
Consultant

Important FAQs about investing in Vyne Therapeutics from India :

What is Vyne Therapeutics share price today?

Vyne Therapeutics share price today stands at $4.00, Open: $3.50 ; Previous Close: $3.46 ; High: $4.00 ; Low: $3.56 ; 52 Week High: $4.00 ; 52 Week Low: $1.57. The stock opens at $3.50, after a previous close of $3.46. The stock reached a daily high of $4.00 and a low of $3.56, with a 52-week high of $4.00 and a 52-week low of $1.57.

Can Indians buy Vyne Therapeutics shares?

Yes, Indians can invest in the Vyne Therapeutics (VYNE) from India.

With INDmoney, you can buy Vyne Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vyne Therapeutics at zero transaction cost.

How can I buy Vyne Therapeutics shares from India?

It is very easy to buy Vyne Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vyne Therapeutics be purchased?

Yes, you can buy fractional shares of Vyne Therapeutics with INDmoney app.

What are the documents required to start investing in Vyne Therapeutics stocks?

To start investing in Vyne Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vyne Therapeutics

Today’s highest price of Vyne Therapeutics (VYNE) is $4.00.

Today’s lowest price of Vyne Therapeutics (VYNE) is $3.56.

What is today's market capitalisation of Vyne Therapeutics

Today's market capitalisation of Vyne Therapeutics VYNE is 44.3M

What is the 52 Week High and Low Range of Vyne Therapeutics

  • 52 Week High

    $4.00

  • 52 Week Low

    $1.57

What are the historical returns of Vyne Therapeutics?

  • 1 Month Returns

    25.82%

  • 3 Months Returns

    76.53%

  • 1 Year Returns

    51.75%

  • 5 Years Returns

    -96.73%

Who is the Chief Executive Officer (CEO) of Vyne Therapeutics

Mr. David T. Domzalski is the current Chief Executive Officer (CEO) of Vyne Therapeutics.